Saving changes...

Done

Error

Advanced Critical Care Therapeutics:Management of Bleeding in the Critical Care Setting

Advanced Critical Care Therapeutics:Management of Bleeding in the Critical Care Setting

Advanced Critical Care Therapeutics:Management of Bleeding in the Critical Care Setting

Daniel E Hilleman, PharmD
Daniel E Hilleman, PharmD
on behalf of Creighton University School of Pharmacy and Health Professions

$ 20.00 $ 20.00 $ 20.00

$ 20.00 $ 20.00 $ 20.00

$ 20.00 $ 20.00 $ 20.00
$ 20.00 $ 20.00 $ 20.00
Normal Price: $ 20.00 $ 20.00

Review:

Launch date: 04 Apr 2017

Expiry Date:

Last updated: 05 Apr 2017

Reference: 177450

$ 20.00 $ 20.00 $ 20.00
$ 20.00 $ 20.00 $ 20.00
Advanced Critical Care Therapeutics:Management of Bleeding in the Critical Care Setting
Exam is embedded in the course
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

A comprehensive course on the Management of Bleeding in the Critical Care Setting as part of the Advanced Critical Care Therapeutic course.

The Advanced Critical Care Therapeutic course provides in-depth advanced instruction concerning the pharmacotherapeutic management of commonly encountered critical care diseases. Emphasis is placed on the efficacy, safety, and comparative value of drug therapy in this highly specialized practice area. Didactic knowledge of physiology, pharmacology, and drug therapy management is applied to disease states specific to this population. Didactic instruction is combined with practice case studies and interactive discussions concerning critical care pharmacy-related issues. Participants may download materials.

Objectives

On completion of this course the learner will:
Be able to describe the bleeding risk and strategies to prevent and to treat bleeding in patients receiving antiplatelet therapy
Be able to define the indications for stress ulcer prophylaxis
Be able to describe the risk factors for bleeding during oral anticoagulant therapy
Be able to describe the management of patients with elevated INR’s on warfarin
Be able to describe the management of bleeding in patients receiving oral single clotting factor inhibitors
Be able to describe the strategy to reduce the risk of bleeding and the management of bleeding in patients receiving heparin drugs
Be able to describe the diagnosis and management of heparin-induced thrombocytopenia (HIT)
Be able to describe the bleeding risk and strategies to prevent and to treat bleeding with fibrinolytic agents
Be able to describe the therapeutic effects of the systemic hemostatic agents 
Daniel E Hilleman, PharmD

Author Information Play Video Bio

Daniel E Hilleman, PharmD
on behalf of Creighton University School of Pharmacy and Health Professions

Professor of Pharmacy
Creighton University School of Pharmacy
and Health Professions
Omaha Nebraska

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error